Lebanon vs Somalia: Access to anti-retroviral drugs, female
Lebanon
69.0%
in 2024
Somalia
70.0%
in 2024
Lebanon rank
84th
Somalia rank
82nd
Access to anti-retroviral drugs, female over time
- Lebanon
- Somalia
How they compare
Somalia currently reports 70.0% against 69.0% in Lebanon, a difference of 1.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Lebanon ahead.
Lebanon ranks 84th and Somalia ranks 82nd of 141 countries.
Lebanon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lebanon | Somalia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.4% | 1.3% | 15.1% | Lebanon |
| 2010s | 42.5% | 29.3% | 13.2% | Lebanon |
| 2020s | 66.8% | 60.4% | 6.4% | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Lebanon or Somalia?
- Somalia, at 70.0% against 69.0% in Lebanon as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Lebanon and Somalia?
- 1.0%, with Somalia ahead.
- How many years of comparable data are there for Lebanon and Somalia?
- 25 years are reported by both, from 2000 to 2024.
- How do Lebanon and Somalia rank globally for access to anti-retroviral drugs, female?
- Lebanon ranks 84th and Somalia ranks 82nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.